Eloxx Pharmaceuticals
@eloxx_pharma
Clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates to treat rare and ultra-rare premature stop codon diseases.
ID: 1281355319185215488
https://www.eloxxpharma.com/ 09-07-2020 22:31:38
74 Tweet
168 Takipçi
32 Takip Edilen
Massachusetts Institute of Technology (MIT)
@mit
The Massachusetts Institute of Technology is a world leader in research and education. Related accounts: @MITevents @MITstudents @MIT_alumni
MIT Technology Review
@techreview
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next.
FierceBiotech
@fiercebiotech
The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
FiercePharma
@fiercepharma
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.
ScienceDaily
@sciencedaily
Your source for the latest research news
Rare Disease Day
@rarediseaseday
29 February 2024 is Rare Disease Day. Raising awareness for patients, families and carers around the world that are affected by rare diseases. #RareDiseaseDay
ASM Newsroom
@asmnewsroom
News from the American Society for Microbiology
BioSpace
@biospace
Your source for biopharma news and jobs
BioWorld
@bioworld
Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Karen Carey, Anette Breindl, Lee Landenberger, Randy Osborne, Mari Serebrov, Caroline Richards
MassBio
@massbio
MassBio is committed to advancing MA's leadership in the life sciences to grow the industry, add value to the healthcare system & improve patient lives.
Applied Microbiology International
@amiposts
Bringing the international microbiology community together to advance scientific impact.
Cystic Fibrosis Foundation
@cf_foundation
Recognized globally, the CF Foundation has led the way in the fight against cystic fibrosis, fueling extraordinary medical and scientific progress.
ALPORT AUSTRALIA
@alportaustralia
National Organization for Rare Disorders (NORD)
@rarediseases
National Organization for Rare Disorders (#NORD) is the voice of the U.S. #RareDisease community for 40+ years strong. Official U.S. sponsor of #RareDiseaseDay.
Global Genes
@globalgenes
Empowering the Next Generation Rare Disease Advocate. Merged with RARE-X Dec. 2022. #CareAboutRare
Microbiology Society
@microbiosoc
Microbiology Society: A world in which the science of #microbiology provides maximum benefit to society | microbiologysociety.org
Adam Feuerstein ✡️
@adamfeuerstein
Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
Alport Syndrome Foundation
@alportsyndfndn
Improving patient lives through education, empowerment, advocacy, and research with a vision to conquer #Alportsyndrome.
DEBRA Canada
@debracanada
Creating awareness about EB & support for families and people suffering from EB.
BioWorld MedTech
@bioworldmedtech
Med-tech's trusted news source. Lynn Yoffee, Holland Johnson, Mark McCarty, Annette Boyle, Shani Alexander
ASM
@asmicrobiology
Official account of the American Society for Microbiology. With over 36,000 members, ASM's mission is to promote & advance the microbial sciences.
Emily's Entourage
@emilysentourage
Accelerating lifesaving research and drug development for the final 10% of people with #cysticfibrosis that don't benefit from mutation-targeted therapies.
debra of America
@debraofamerica
Leading national nonprofit improving the lives of those impacted by Epidermolysis Bullosa (EB) —"The Worst Disease You've Never Heard Of."
Cystinosis CRN
@cystinosiscrn
Cystinosis Research Network is dedicated to supporting research, providing family outreach & educating the public & medical communities about #cystinosis
Pink Sheet, Citeline Regulatory
@pharmapinksheet
Pink Sheet delivers analysis & commentary focused on regulatory implications, including high value perspectives from insiders & thought leaders across the globe
EB Research Partnership
@ebresearch
EB Research Partnership funds research aimed at treating and curing Epidermolysis Bullosa (EB). 🦋 #HealEB 🔬 Find a cure
CF News Today
@cfnewstoday
We are dedicated to sharing the latest news, research, and patient perspectives from the CF community.
Alport UK
@alportuk
Alport UK is a patient-led organisation dedicated to empowering people living with Alport Syndrome to enjoy the best possible quality of life.
STAT
@statnews
Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: statnews.com/signup
Endpoints News
@endpts
The biopharma world is here. Get the industry’s most comprehensive daily news reports at endpts.com/subscribe
Cure Rare Disease
@cureraredisease
501(c)(3) nonprofit leading a nationwide collaboration of researchers and clinicians in order to develop life-saving therapeutics for rare diseases.
DEBRA International
@interdebra
For a world where anyone with epidermolysis bullosa (EB) has support from a DEBRA group, and access to specialist treatments, healthcare, and social support.